News Focus
News Focus
icon url

familyof5

08/20/24 3:57 PM

#178923 RE: LeAcc #178922

I don't anticipate it taking the full 45 days to remedy. Nor do I see where it would be beneficial dragging the resubmission out if that extra time is not needed. Dr. Korenko did state on the 29th of July WITHIN 45 days. We're now 23 days in. I would think Dr.Korenko would PR the event at a time of his own choosing that would be most impactful and beneficial (AFTER MARKET CLOSE or PREMARKET OPEN) to those of whom have had the courage and loyalty to hold through the good and bad (Those impacted by the PREMARKET delay PR July 29th), the thick and thin. And at a time ye think not. This is not a view intended to create a sense of FOMO urgency or hysteria. But my own personal PERCEPTION of how things play out here. Remember, the current goal is to position, and to be in the position, to RESUBMIT the IDE application with the FDA's follow up request satisfied, and with the FDA's blessing. I have been RIGHT ON with my calls here more than RIGHT but a little OFF. I can say with a fair sense of confidence that I think this will be the case once again. But what do I know. I just showed up a month or two back RIGHT?..... by the way.....that so called stubborn break through of the .12 cent level will be surpassed here sooner rather than later....tick tock


JULY 29TH Press Release:

We are confident that thus far our submissions have provided 90-95% percent of the information they require and that Vivos will be able to resubmit the refined IDE application with high quality responses demonstrating a compelling risk/benefit analysis to the FDA within the next 45 days.



AUGUST 16TH
icon url

familyof5

08/20/24 4:46 PM

#178925 RE: LeAcc #178922

Yes that's been their MO for a few months now. ASCM is running interference for someone who's interest's are in conflict with those of our own, and I would add, RDGL's management. They appeared as a RDGL MARKET MAKER for the first time this current year 5 months ago back in APRIL (ASCM was no where to be found the first 3 months of this year). There is a .15 cent share offering out there that has not been aggressively shopped around imho. I couldn't imagine some entity, or individual, interested in this offering trying to cap the upside of the PPS in hopes of getting a more lucrative entry point by creating unwarranted pressure on the stocks PPS (Add sarcasm). Shorting maybe, or is it just an effort to create the artificial perception that there is resistance to the upside? The trading strategy here with ASCM does not have the appearance of being organic in nature or a random event. Absent of ASCM RDGL would currently be traded at a much higher PPS. They are the only real resistance here no and's, if's, buts, or maybe's. The current drag on the PPS facilitated by this certain MARKET MAKER has very little to do with any uncertainty surrounding FDA resubmission (That could very easily be any day now) and a whole lot to do with ASCM's presence here and the underlying reason for such....ASCM does move rather easy and with little resistance when having their artificial non organic ASK hit. And yes it couldn't be more obvious that ASCM doesn't like being placed second on the RDGL BIDDERS list.....Hard for the fox to be guarding the hen house if he's not being allowed access. Or in this case opportunity.....